RCMI Coordinating Center (RCMI CC) Header Logo

Connection

J Goodwin to Lung Neoplasms

This is a "connection" page, showing publications J Goodwin has written about Lung Neoplasms.
Connection Strength

4.031
  1. Doan C, Li S, Goodwin JS. Breast and Lung Cancer Screening Among Medicare Enrollees During the COVID-19 Pandemic. JAMA Netw Open. 2023 02 01; 6(2):e2255589.
    View in: PubMed
    Score: 0.539
  2. Goodwin JS, Li S. Clinician and Patient Characteristics Associated With Lung Cancer Screening Following a Shared Decision-making Visit. JAMA Netw Open. 2020 10 01; 3(10):e2021197.
    View in: PubMed
    Score: 0.458
  3. Nishi SPE, Zhou J, Okereke I, Kuo YF, Goodwin J. Use of Imaging and Diagnostic Procedures After Low-Dose CT Screening for Lung Cancer. Chest. 2020 02; 157(2):427-434.
    View in: PubMed
    Score: 0.426
  4. Goodwin JS, Nishi S, Kuo YF. Physicians' Responsibilities in Shared Decision Making for Lung Cancer Screening-Reply. JAMA Intern Med. 2019 07 01; 179(7):995-996.
    View in: PubMed
    Score: 0.420
  5. Goodwin JS, Nishi S, Zhou J, Kuo YF. Use of the Shared Decision-Making Visit for Lung Cancer Screening Among Medicare Enrollees. JAMA Intern Med. 2019 05 01; 179(5):716-718.
    View in: PubMed
    Score: 0.415
  6. Sharma G, Wang Y, Graham JE, Kuo YF, Goodwin JS. Provider continuity prior to the diagnosis of advanced lung cancer and end-of-life care. PLoS One. 2013; 8(9):e74690.
    View in: PubMed
    Score: 0.281
  7. Holmes HM, Bain KT, Zalpour A, Luo R, Bruera E, Goodwin JS. Predictors of anticoagulation in hospice patients with lung cancer. Cancer. 2010 Oct 15; 116(20):4817-24.
    View in: PubMed
    Score: 0.230
  8. Gopal M, Abdullah SE, Grady JJ, Goodwin JS. Screening for lung cancer with low-dose computed tomography: a systematic review and meta-analysis of the baseline findings of randomized controlled trials. J Thorac Oncol. 2010 Aug; 5(8):1233-9.
    View in: PubMed
    Score: 0.227
  9. Sharma G, Freeman J, Zhang D, Goodwin JS. Continuity of care and intensive care unit use at the end of life. Arch Intern Med. 2009 Jan 12; 169(1):81-6.
    View in: PubMed
    Score: 0.204
  10. Wang J, Kuo YF, Freeman J, Markowitz AB, Goodwin JS. Temporal trends and predictors of perioperative chemotherapy use in elderly patients with resected nonsmall cell lung cancer. Cancer. 2008 Jan 15; 112(2):382-90.
    View in: PubMed
    Score: 0.190
  11. Sharma G, Freeman J, Zhang D, Goodwin JS. Trends in end-of-life ICU use among older adults with advanced lung cancer. Chest. 2008 Jan; 133(1):72-8.
    View in: PubMed
    Score: 0.187
  12. Wang J, Kuo YF, Freeman J, Goodwin JS. Increasing access to medical oncology consultation in older patients with stage II-IIIA non-small-cell lung cancer. Med Oncol. 2008; 25(2):125-32.
    View in: PubMed
    Score: 0.185
  13. Lackan NA, Ostir GV, Freeman JL, Mahnken JD, Goodwin JS. Decreasing variation in the use of hospice among older adults with breast, colorectal, lung, and prostate cancer. Med Care. 2004 Feb; 42(2):116-22.
    View in: PubMed
    Score: 0.144
  14. Sharma G, Nishi SP, Lin YL, Kuo YF, Goodwin JS, Riall TS. Pattern of Imaging after Lung Cancer Resection. 1992-2005. Ann Am Thorac Soc. 2016 09; 13(9):1559-67.
    View in: PubMed
    Score: 0.086
  15. Lackan NA, Ostir GV, Freeman JL, Kuo YF, Zhang DD, Goodwin JS. Hospice use by Hispanic and non-Hispanic white cancer decedents. Health Serv Res. 2004 Aug; 39(4 Pt 1):969-83.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support